 |
|
Creeping Eruption Treated With Thiabendazole
JACKSONVILLE DERMATOLOGY SOCIETY
Arch Dermatol. 1965;91(5):425-426.
Abstract
Members of the Jacksonville Dermatology Society have treated 51 patients with active creeping eruption with oral thiabendazole. No single- or double-blind placebo controls were used. There were no severe toxic reactions from the drug in the dosage of 25 mg/kg of body weight twice a day. Observation during the patients' hospitalization and results of their laboratory tests lead us to believe that thiabendazole is a relatively safe drug and might be given without hospitalization of the patient. Our results to date have been encouraging for a disease that hitherto has had no satisfactory treatment. Even the seven cases that did not respond entirely received no less than a "good" rating by both doctor and patient. The posttreatment follow-up ranged from one week to one month. During this time none of 44 responsive patients developed relapses of their disease. In our program 25 mg/kg of body weight for 3 to 4 days seems the best treatment schedule.
Author Affiliations
JACKSONVILLE, FLA
Members of the Jacksonville Dermatology Society; Jack Bowen, MD; William Croom, MD; Marvin Engel, MD; William Eyster, MD; Joseph Farrington, MD; William Garvin, MD; Louis Hubener, MD; William Lawson, MD; Lauren Sompayrac, MD; and James Trimble, MD.
Footnotes
Accepted for publication Jan 12, 1965.
Reprint requests to Suite 305, Marshall Taylor Doctors Building, Jacksonville, Fla 32207 (Dr. Sompayrac).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Hookworm Folliculitis
Miller et al.
Arch Dermatol 1991;127:547-549.
ABSTRACT
Thiabendazole-Induced Toxic Epidermal Necrolysis
Robinson and Samorodin
Arch Dermatol 1976;112:1757-1760.
ABSTRACT
Local Thiabendazole in the Treatment of Creeping Eruption
Eyster
Arch Dermatol 1967;95:620-621.
ABSTRACT
|
